| Also known as |
DRSP |
| Blood pressure |
May increase slightly, monitor in patients with hypertension |
| Chemical name |
(6R,7R,8R,9S,10S,13S,14S,15S,16S,17S)-1,3',4',6,6',7,8,9,10,13,14,15,16,17,17a-hexadecahydro-10,13-dimethylspiro-[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2'(5'H)-furan]-3,5'(2H)-dione |
| Dosage (medical) |
Commonly 3 mg/day in combination with ethinyl estradiol for contraception |
| Dosage (sports) |
Not applicable |
| Effects |
Prevention of ovulation, increased cervical mucus viscosity |
| Formula |
C24H30O3 |
| Half-life |
Approximately 30 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Not specific, but hormone levels can be monitored |
| Main action |
Progestogenic activity, anti-mineralocorticoid activity, and weak antiandrogenic activity |
| Raw Material |
Ethinyl Estradiol , Drospirenone |
| Side effects |
Breast tenderness, headache, nausea, bloating, mood changes |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Synthetic steroidal progestin |
| Trade name |
Yasmin, Yaz, others |
| Use in sports |
None |
| Water Retention |
Low (due to anti-mineralocorticoid properties) |
| Manufacturer |
Schering |
| Packing |
28 tabs (3mg+0.02mg) |
